Location History:
- Notting Hill, AU (2013 - 2015)
- Alpharetta, GA (US) (2017)
Company Filing History:
Years Active: 2013-2017
Title: Gary Pitt: Innovator in Viral Infection Treatment
Introduction
Gary Pitt is a notable inventor based in Notting Hill, Australia. He has made significant contributions to the field of medicine, particularly in the treatment of viral infections. With a total of three patents to his name, Pitt's work focuses on innovative compounds that target respiratory syncytial virus (RSV) infections.
Latest Patents
Pitt's latest patents include two related inventions. The first patent involves substituted imidazo[1,2-d]pyrrolo[1,2-d]pyrazines, which are compounds useful in treating RSV infections. This invention details the compounds of formula (I), including their salts, isomers, or prodrugs, and outlines the processes for preparing these compounds and the intermediates used in their preparation. The second patent similarly addresses substituted imidazo[1,2-a]pyrrolo[1,2-d]pyrazines for treating RSV infections, emphasizing the same aspects of compound formulation and preparation processes.
Career Highlights
Gary Pitt is currently associated with Biota Scientific Management Pty Ltd, where he continues to advance his research and development efforts. His work has been instrumental in creating effective treatments for viral infections, showcasing his dedication to improving public health.
Collaborations
Pitt collaborates with esteemed colleagues, including Jeffrey Peter Mitchell and Alistair George Draffan. Their combined expertise contributes to the innovative research and development efforts at Biota Scientific Management Pty Ltd.
Conclusion
In summary, Gary Pitt is a distinguished inventor whose work in developing treatments for respiratory syncytial virus infections has made a significant impact in the medical field. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.